日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

COREGO: drug-drug interaction analysis on the efficacy and safety of regorafenib in patients with a sarcoma: pooled analysis of the data from the REGOSARC and REGOBONE trials

COREGO：瑞戈非尼治疗肉瘤患者的疗效和安全性药物相互作用分析：REGOSARC 和 REGOBONE 试验数据的汇总分析

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105117
Rethouze, F; Risbourg, S; Schiffler, C; Chabaud, S; de Courrèges, A; Le Deley, M-C; Blay, J Y; Feutry, F; Jimenez, M; Vanseymortier, M; Penel, N; Duffaud, F; Lebellec, L
ARC
发表日期：2025
文献求助 收藏

Relative Dose Intensity of Trabectedin and Outcome of Advanced L-Sarcomas

曲贝替定相对剂量强度与晚期L肉瘤预后的关系

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.71131
Poitureau, Stephen; Le Deley, Marie-Cécile; Brahmi, Mehdi; Bompas, Emmanuelle; Kurtz, Jean-Emmanuel; Nannini, Simon; Perrin, Christophe; Lebellec, Loïc; Ryckewaert, Thomas; Ould-Ammar, Redha; Leguillette, Clémence; Blay, Jean-Yves; Penel, Nicolas
发表日期：2025
文献求助 收藏

FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma

FOLFIRINOX方案在晚期胰腺腺癌中的相对剂量强度和疾病控制情况

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359211029825
Vary, Antonin; Lebellec, Loïc; Di Fiore, Frédéric; Penel, Nicolas; Cheymol, Claire; Rad, Emilia; El Hajbi, Farid; Lièvre, Astrid; Edeline, Julien; Bimbai, André Michel; Le Deley, Marie-Cécile; Turpin, Anthony
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Anti-Angiogenic Agents in Management of Sarcoma Patients: Overview of Published Trials

抗血管生成药物在肉瘤患者治疗中的应用：已发表试验概述

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2020.594445
Cren, Pierre-Yves; Lebellec, Loïc; Ryckewaert, Thomas; Penel, Nicolas
血管生成
发表日期：2020
文献求助 收藏

Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial

接受每周一次紫杉醇联合或不联合贝伐珠单抗治疗的血管肉瘤患者的预后和预测因素：一项源自随机临床试验的辅助研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-018-4828-1
Lebellec, Loïc; Bertucci, François; Tresch-Bruneel, Emmanuelle; Ray-Coquard, Isabelle; Le Cesne, Axel; Bompas, Emmanuelle; Blay, Jean-Yves; Italiano, Antoine; Mir, Olivier; Ryckewaert, Thomas; Toiron, Yves; Camoin, Luc; Goncalves, Anthony; Penel, Nicolas; Le Deley, Marie-Cécile
发表日期：2018
文献求助 收藏

Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group (GSF/GETO)

循环血管内皮生长因子 (VEGF) 作为索拉非尼治疗晚期脊索瘤患者无进展生存期的预测因子：法国肉瘤组 (GSF/GETO) II 期试验的分析

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.12172
Lebellec, Loic; Bertucci, François; Tresch-Bruneel, Emmanuelle; Bompas, Emmanuelle; Toiron, Yves; Camoin, Luc; Mir, Olivier; Laurence, Valerie; Clisant, Stephanie; Decoupigny, Emilie; Blay, Jean-Yves; Goncalves, Anthony; Penel, Nicolas
VEGF
EGF
心血管
发表日期：2016
文献求助 收藏

Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)

索拉非尼治疗局部晚期和转移性脊索瘤患者：法国肉瘤组 (GSF/GETO) 的 II 期试验

期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdv300
Bompas, E; Le Cesne, A; Tresch-Bruneel, E; Lebellec, L; Laurence, V; Collard, O; Saada-Bouzid, E; Isambert, N; Blay, J Y; Amela, E Y; Salas, S; Chevreau, C; Bertucci, F; Italiano, A; Clisant, S; Penel, N
发表日期：2015
文献求助 收藏